Stock BIIB34 BIOGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Biogen Inc. Sao Paulo

Equities

BIIB34

BRBIIBBDR001

Delayed Sao Paulo
Other stock markets
 11:35:44 03/07/2024 pm IST 		5-day change 1st Jan Change
211.9 BRL -1.43% Intraday chart for Biogen Inc. -1.43% +3.25%
02/07 US Equities Markets End Higher Tuesday Following Fed Chair Powell's Comments MT
02/07 Equity Markets Mostly Rise Intraday After Fed Chair Powell's Comments MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
US Equities Markets End Higher Tuesday Following Fed Chair Powell's Comments
Equity Markets Mostly Rise Intraday After Fed Chair Powell's Comments
Eli Lilly Alzheimer's drug approved by US FDA
Biogen Closes Human Immunology Biosciences Acquisition
Japan's Eisai developing dementia drug for US market, Nikkei reports
Eisai and Biogen launch Alzheimer's drug Leqembi in China
Eisai Co., Ltd. and Biogen Inc. Announces Launch of Leqembi in China
Immunome, Inc. Appoints Phil Tsai as Chief Technical Officer
REGENXBIO Inc. Announces Chief Executive Officer Changes
Biogen executive plays down looming competition for its Alzheimer's drug
BIOGEN EXEC SAYS THE ALZHEIMER'S DRUG MARKET "WILL DEVELOP FASTE…
Japan's Nikkei gains on chip shares boost; Fed policy in focus
Panel asesor de la FDA vota a favor de los datos del fármaco contra el Alzheimer de Lilly
FDA advisory panel votes in favor of data for Lilly Alzheimer's drug
US FDA advisers to review Eli Lilly Alzheimer's drug
Biogen, Eisai Say Alzheimer's Maintenance Treatment Application Accepted by US FDA
Fda Accepts Eisai's Filing of Leqembi® (Lecanemab-Irmb) Supplemental Biologics License Application for Iv Maintenance Dosing for the Treatment of Early Alzheimer's Disease
US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug
Italien hat Novartis und weitere Pharmafirmen wegen Augenarznei im Visier
Italienische Wettbewerbsbehörde nimmt vier Pharmakonzerne ins Visier
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIIB Stock
  4. BIIB34 Stock
  5. News Biogen Inc.
  6. Other languages